Medical technology pioneer AstraZeneca has chosen the Cambridge Biomedical Campus at the Addenbrooke’s Hospital site in Cambridge UK for its new global headquarters.

Cambridge UK medical technology business Phytopharm reported an unaudited post-tax loss of £2.65 million for the six months to the end of March but it was the cash burn that evidenced the reasons for the company’s urgent restructuring.

A novel inhaler for cystic fibrosis suffers using saltwater treatment has been developed in a Cambridge UK-North Carolina technology alliance.

Cambridge medical technology business Phytopharm plc has suspended trading on the UK’s main market pending a potentially transformational acquisition which is at the heart of an urgent restructuring.

Inhaled therapies pioneer Vectura, which has operations in the Cambridge UK technology cluster, plans to use some of its £70 million war chest for fresh commercial ventures to accelerate growth.

The Queen is to officially open the new building for the Medical Research Council  (MRC) Laboratory of Molecular Biology at the heart of the Cambridge UK technology cluster on Thursday, May 23.

Babraham Institute in Cambridge has formed a new venture to commercialise its vast IP portfolio and expand collaboration opportunities with global researchers and companies – a move that boosts the UK’s capabilities for medical technology innovation.

A Cambridge-Belgium technology collaboration has created a device which helps people whose speech has been impaired by crippling conditions to find their voice.